This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Mithra Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Christophe Marechal
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 7.6yrs |
| CEO ownership | n/a |
| Management average tenure | 4.4yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%
Apr 06
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive
Feb 07Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts
Nov 09These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts
Oct 05Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)
May 23Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts
Aug 11Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%
Mar 13Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt
Dec 22Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 24Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt
Jun 07When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?
May 10Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?
Mar 18We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings
Feb 16Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long
Jan 21
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 29CEO
Christophe Marechal
7.6yrs
Tenure
Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-CEO & CFO | 7.6yrs | no data | no data | |
| COO & Co-CEO | less than a year | no data | no data | |
| Chief Scientific Officer | 5.2yrs | no data | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Secretary of the Board & General Counsel | no data | no data | no data | |
| Compliance Officer | no data | no data | no data | |
| Communication Director | no data | no data | no data | |
| HR Director | no data | no data | no data | |
| Chief Business Officer | 3.7yrs | no data | 0.000040% € 4.9 | |
| President of the Scientific Advisory Board & Executive Director | no data | €7.12k | 0.029% € 3.6k | |
| Head of Global Regulatory Affairs | no data | no data | no data | |
| Head of Program & Project Management | no data | no data | no data |
4.4yrs
Average Tenure
Experienced Management: MITRA's management team is considered experienced (4.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President of the Scientific Advisory Board & Executive Director | 8yrs | €7.12k | 0.029% € 3.6k | |
| Independent & Non-Executive Director | 1.7yrs | €25.00k | no data | |
| Non-Executive Director | 2.8yrs | €20.00k | 0.042% € 5.1k |
2.8yrs
Average Tenure
Experienced Board: MITRA's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.